Žarko V.
- Country
- Croatia
- Department
- Pulmonology
Research Overview
- Phase 3 Randomized, Double-Blind Study of Belrestotug and Dostarlimab Versus Pembrolizumab in PD-L1 High Non-Small Cell Lung Cancer
- Efficacy and Safety of Tanimilast DPI as Add-On to Triple Therapy in Chronic Obstructive Pulmonary Disease with Chronic Bronchitis
- Phase 3 Study of Acasunlimab and Pembrolizumab Versus Docetaxel in PD-L1 Positive Metastatic NSCLC Post PD-1/PD-L1 Inhibitor and Platinum Chemotherapy
Data & Insights
Has run more than one trial at 31 of 312 partner sites.
Specializations
Respiratory Medicine
The investigator specializes in treating Chronic Obstructive Pulmonary Disease (COPD), with particular focus on developing advanced therapeutic approaches using combination treatments. Their research explores innovative respiratory interventions, specifically examining the integration of maintenance therapies for COPD management.
- Triple therapy optimization
- COPD exacerbation management
- Long-term respiratory care
The therapeutic approach encompasses comprehensive COPD treatment strategies, focusing on reducing exacerbation frequency and improving patient outcomes.
Oncology
This investigator demonstrates significant expertise in treating Non-Small Cell Lung Cancer (NSCLC), particularly focusing on advanced-stage disease management. Their work involves evaluating novel therapeutic combinations and immunotherapy approaches.
- Metastatic NSCLC treatment
- Immunotherapy combinations
- Second and third-line therapies
The research focus includes developing innovative treatment strategies for patients who have progressed after standard therapies.
Precision Oncology
The investigator's expertise extends to targeted therapy approaches in lung cancer, with specific attention to PD-L1 expression levels and personalized treatment strategies. Their work encompasses evaluation of novel therapeutic combinations for specific patient populations.
- PD-L1 targeted treatments
- First-line therapy optimization
- Biomarker-driven approaches
Their research focuses on developing precision medicine approaches for lung cancer treatment, particularly in previously untreated patients.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.